Lankenau Ventures Launches First Device Developed by Healthcare Hero

Lankenau Ventures is a joint venture between Early Charm, L2C Partners, and Lankenau Institute for Medical Research.

April 24, 2024 Baltimore, MD – Colleen Rogers, RN, a renowned wound care nurse, had an idea for a product that would help her and her colleagues better care for their patients. But she didn’t have the funds or engineering know-how to create the device she envisioned alone.

Today, after years of considering her idea, Rogers saw it finally brought to life – with the launch of the Rogers Limb Support. The device is the first to be launched by Lankenau Ventures, a company that manufactures and markets products invented by frontline healthcare workers.

Rogers knew that nurses struggle to tend to patients’ limb injuries alone, often requiring the help of one or more others to change bandages on a leg or foot. She conceptualized a device that could prop up a weak or injured limb, enabling a nurse to provide care independently and efficiently. The device would be of particular help in caring for patients with diabetes, who frequently have such chronic wounds.

The people who know best what healthcare providers need to do their jobs well and take the best care of their patients are the providers themselves. That is the thesis behind Lankenau Ventures, which was formed in 2021 through a partnership between Baltimore’s Early Charm, L2C Partners, and Lankenau Institute for Medical Research, part of Main Line Health, a system serving Philadelphia and its suburbs. Lankenau Ventures’ team of designers, engineers, and business development personnel works directly with healthcare inventors to bring their ideas for new medical tools and technologies to life.

The Rogers Limb Support device, named for its inventor, offers a better approach for providing limb care. It not only reduces the number of nurses needed to change a bandage but also reduces the physical strain that holding a limb up puts on nurses’ bodies. The device softly launched in November 2023 when the first order of devices was delivered to all five Main Line Health hospitals. The Lankenau Ventures team has since demonstrated the device at wound care conferences and worked with clinicians at Main Line Health to gather input on the product’s design and functionality in preparation for today’s official launch.

“The device is very intuitive. Any time we have demoed it, healthcare providers immediately see the value and how it can help with patient care,” said Kelsey Abernathy, manager of commercial development at Lankenau Ventures.

The device is manufactured in the USA and is designed to be lightweight, height adjustable, and easy to clean, making it ideal for multi-patient use in a healthcare setting.

The Rogers Limb Support is the first of several healthcare-worker-invented products in the Lankenau Ventures pipeline. Additional products in development include a device that provides safety and privacy for patients who need assistance in the restroom during a hospital stay and a device that facilitates easy catheter insertion for female patients.

About Lankenau Institute for Medical Research:

Lankenau Insitute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians. https://limr.mainlinehealth.org/

About L2C Partners:

L2C Partners, founded in 2015 by Merle Gilmore, provides outsourced technology transfer and commercialization services in the pharma, bioscience and tech categories for educational institutions and research centers. https://www.l2cpartners.com/

About Early Charm:

Early Charm, founded in 2012 in Charm City (Baltimore), converts science into products in the areas of advanced materials, computational sciences, and engineered products. Learn more: www.earlycharm.com

Media Contact:

Kelsey Abernathy Manager of Commercial Development kelsey.abernathy@lankenauventures.com